Cardiac inflammation and innate immunity in septic shock: Is there a role for toll-like receptors?

Chest

Volumn 121, Issue 4, 2002, Pages 1329-1336

  Knuefermann, Pascal ^a   Nemoto, Shintaro ^a   Baumgarten, Georg ^a   Misra, Arunima ^a   Sivasubramanian, Natarajan ^a   Carabello, Blasé A ^a   Vallejo, Jesus G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Innate immunity; Myocardial dysfunction; Septic shock; Toll like receptors

Indexed keywords

CD14 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PATTERN RECOGNITION RECEPTOR; RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

HEART FUNCTION; HUMAN; IMMUNE RESPONSE; IMMUNITY; INCIDENCE; MOLECULAR MECHANICS; MORTALITY; MYOCARDIAL DISEASE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SURVIVAL;

EID: 0036204061     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.4.1329     Document Type: Article

References (66)

1. Increase in national hospital discharge: Survey rates for septicemia-United States, 1979-1987
2. Gram-positive organisms and sepsis
3. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration
4. Congenital deficiency of nitric oxide synthase 2 protects against endotox-in-induced myocardial dysfunction in mice
5. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia
6. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: The role of toll-like receptor-4
7. Differential regulation of myocardial NF-κB following acute or chronic TNF-κ exposure
8. Epidemiology and clinical impact of gram-negative sepsis
9. Sepsis: A new hypothesis for pathogenesis of the disease process
10. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
11. Improved survival of patients with acute respiratory distress syndrome (ARDS), 1983-1993
12. New criteria for selecting the proper antimicrobial chemotherapy for severe sepsis and septic shock
13. The pathogenesis of sepsis
14. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome
15. Plasma tumor necrosis factor and mortality in critically ill septic patients
16. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
17. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
18. Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis
19. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: A randomized, controlled, double-blind, multicenter clinical trial
20. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock
21. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock: A randomized controlled multicenter trial
22. Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: A multicenter, randomized, placebo-controlled, dose- ranging study
23. Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein
24. Innate immunity
25. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide
26. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice
27. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
28. A family of human receptors structurally related to Drosophila Toll
29. The interleukin-1 receptor/Toll-like receptor superfamily: Signal generators for pro-inflammatory interleukins and microbial products
30. Cloning and characterization of two Toll/Interleukin-1 receptor-like genes TIL3 and TIL4: Evidence for a multi-gene receptor family in humans
31. TLR6: A novel member of an expanding toll-like receptor family
32. A Toll-like receptor recognizes bacterial DNA
33. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5
34. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
35. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)
36. Genetic and physical mapping of the Lps locus: Identification of the toll-4 receptor as a candidate gene in the critical region
37. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide; evidence for TLR4 as the Lps gene product
38. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
39. Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2
40. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
41. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products
42. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
43. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
44. IRAK: A kinase associated with the interleukin-1 receptor
45. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling
46. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex
47. The human toll signaling pathway: Divergence of nuclear factor-κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6)
48. Profound but reversible myocardial depression in patients with septic shock
49. Tumor necrosis factor challenges in canines: Patterns of cardiovascular dysfunction
50. Left ventricular diastolic function in sepsis
51. A circulating myocardial depressant substance in humans with septic shock: Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance
52. Tumor necrosis factor-α causes myocardial depression in guinea pigs
53. Load-insensitive assessment of myocardial performance after tumor necrosis factor-alpha in dogs
54. Tumor necrosis factor α and interleukin 1β are responsible for in vitro myocardial cell depression induced by human septic shock serum
55. Tumor necrosis factor-α and interleukin-1β synergistically depress human myocardial function
56. Cellular basis for the negative inotropic effects of tumor necrosis factor-α in the adult mammalian heart
57. Nitric oxide synthase inhibition does not prevent cardiac depression in endotoxic shock
58. Nitric oxide synthase is not involved in cardiac contractile dysfunction in a rat model of endotoxemia without shock
59. Endotoxin-induced myocardial tumor necrosis factor-α synthesis depresses contractility of isolated rat hearts: Evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production
60. Tumor necrosis factor-α (TNF-α) plays a protective role in acute viral myocarditis in mice: A study using mice lacking TNF-α
61. LPS-induced TNF-α release from and apoptosis in rat cardiomyocytes: Obligatory role for CD14 in mediating the LPS response
62. CD14-independent activation of cardiomyocyte signal transduction by bacterial endotoxin
63. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
64. Role of TLR-2 in the activation of nuclear factor κB by oxidative stress in cardiac myocytes
65. Role of gene deletion of the Toll-like receptor-4 (TLR-4) in lipopolysaccharide (LPS)-induced left ventricular dysfunction
66. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation